Research.Patient.info
Platinum-resistant Ovarian Cancer research hub
2 indexed studies · 1 currently recruiting
- recruitingPHASE1
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
This study is testing a new drug, CTIM-76, for some difficult-to-treat cancers like ovarian, testicular, and endometrial cancer. It's an early-stage study to check for safety and find the right dose. The drug works by helping your immune system fight the cancer.
United States · United Kingdom - active not recruitingNA
Low-Dose CT - Stage I Testicular Cancer
This study looks at using lower-dose X-rays (CT scans) to check for testicular cancer recurrence in men already on watch-and-wait. The goal is to see if these lower-dose scans are just as good as standard scans at finding problems, while also reducing radiation exposure, which might lower the risk of future cancers.
Canada